USPTO serial 88015911
HEALIOS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 7, 2023
- Examiner
- FOSDICK, GEOFFREY A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HEALIOS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
Minato-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin ALPRIN LAW OFFICES PC5 PINEHURST CIRCLE NWWASHINGTON, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; biological preparations for veterinary purposes for the treatment of cancer, liver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, liver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 14, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 12, 2022 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Oct 12, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 7, 2022 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Oct 7, 2022 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Oct 5, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 8, 2022 | TPAD | TEAS PETITION TO AMEND BASIS RECEIVED | — |
| Mar 29, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 25, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 25, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 25, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 14, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 17, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 17, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 10, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 19, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 17, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 17, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 17, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 12, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 26, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2020 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 8, 2019 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 8, 2019 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Nov 8, 2019 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Oct 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 23, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 23, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 23, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 17, 2019 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Jul 17, 2019 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Jul 17, 2019 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Jul 1, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jul 1, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 23, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 23, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 23, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 9, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 16, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2018 | NWAP | NEW APPLICATION ENTERED | — |